4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000017
Chief Financial Officer acquired 9,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-15 | Option exercise | +9,000 | $2.10 | $18,900 | 83,170 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-15 | Option exercise · Stock Option (Right to Buy) | −9,000 | 43,157 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1710880362.xml…